{"id":8036,"date":"2019-05-15T20:35:11","date_gmt":"2019-05-15T20:35:11","guid":{"rendered":"https:\/\/ambrosecelltherapy.com\/?p=8036"},"modified":"2022-01-19T13:06:11","modified_gmt":"2022-01-19T17:06:11","slug":"real-stem-cell-therapy-outcomes-222","status":"publish","type":"post","link":"https:\/\/ambrosecelltherapy.com\/ar\/real-stem-cell-therapy-outcomes-222\/","title":{"rendered":"\u0646\u062a\u0627\u0626\u062c \u0627\u0644\u0639\u0644\u0627\u062c \u0628\u0627\u0644\u062e\u0644\u0627\u064a\u0627 \u0627\u0644\u062c\u0630\u0639\u064a\u0629 \u0627\u0644\u062d\u0642\u064a\u0642\u064a\u0629"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Hero” _builder_version=”3.22.3″ background_image=”https:\/\/ambrosecelltherapy.com\/wp-content\/uploads\/2018\/12\/Cover-Revision-e1544054347204.jpg” background_blend=”multiply” custom_padding=”|||” animation_style=”zoom” animation_intensity_zoom=”4%” global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ background_blend=”multiply” max_width=”80%” custom_padding=”40px|||” animation_style=”slide” animation_direction=”top” animation_intensity_slide=”3%” use_custom_width=”on” width_unit=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_post_title meta=”off” featured_image=”off” text_color=”light” _builder_version=”3.21″ title_font=”|700||on|||||” title_font_size=”40px” text_shadow_style=”preset2″ global_colors_info=”{}”][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Main body” _builder_version=”3.22.3″ custom_margin=”|||” custom_padding=”50px||3px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ animation_style=”fade” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ global_colors_info=”{}”]

\"Matthew<\/a>

Click to listen in full to Episode 45 of Living Beyond 120 as AMBROSE CEO Matthew Feshbach delves into real patient stories and the importance of monitoring stem cell therapy outcomes.<\/p><\/div><\/p>\n

CEO and Founder Matthew Feshbach recently returned as a guest on anti-aging and wellness podcast Living Beyond 120<\/em> to talk stem cell therapy outcomes and real AMBROSE patient stories.<\/p>\n

Why Patient Outcomes Matter<\/strong><\/h3>\n

With more than 98 million adults in the United States living with 2 or more chronic conditions, AMBROSE evaluates the common factors of chronic disease and addresses them in a single procedure utilizing patients’ own adult stem and regenerative cells derived from adipose (fat tissue).<\/p>\n

AMBROSE operates under Texas “right to try” legislation (House Bill 810, also known as Charlie’s Law) and approaches investigational stem cell treatments at a serious clinical level, offering patients a safe, regulated environment in which to explore stem cells for improved symptoms, function and quality of life. AMBROSE patient outcomes are examined as part of the Adipose Cell Therapy for Chronic Inflammation<\/em> (ACT-CI) registry study<\/a>, conducted under said legislation, the purpose of which is to assess the safety, feasibility and effectiveness of using patient’s own cells to treat severe, chronic conditions.<\/p>\n

By closely monitoring and reporting on our outcomes, we hope to help more patients gain access to this potentially life-changing therapy and to set a new standard of safety and care in the process.<\/p>\n

“Real Stem Cell Therapy Outcomes” – The Interview<\/strong><\/h3>\n

In this episode of Living Beyond 120<\/em>, Dr. Jeffrey R. Gladden, MD, FACC, and host Mark Young talk with Feshbach about real patient stories, delving into stem cell therapy outcomes experienced by patients suffering from serious and debilitating conditions<\/a> such as:<\/p>\n